Evidence map›Paper›PMID 34331386›Full record

ArticleAmerican journal of medical genetics. Part A2021

Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).

Alessandro Iannaccone, Carmen C Brewer, Peiyao Cheng, Jacque L Duncan, Maureen G Maguire, Isabelle Audo, Allison R Ayala, Paul S Bernstein, Gavin M Bidelman, Janet K Cheetham and 7 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2A.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
    Observational
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 3 countries.

Alessandro IannacconeDuke Eye Center, Department of Ophthalmology, Duke University Medical School, Durham, North Carolina, USA.
Carmen C BrewerNational Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, USA.ORCID 0000-0003-1462-049X
Peiyao ChengJaeb Center for Health Research, Tampa, Florida, USA.
Jacque L DuncanUniversity of California, San Francisco, San Francisco, California, USA.
Maureen G MaguireUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
Isabelle AudoInstitut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.
Allison R AyalaJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-1483-7536
Paul S BernsteinMoran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Gavin M BidelmanUniversity of Memphis, Memphis, Tennessee, USA.
Janet K CheethamFoundation Fighting Blindness, Columbia, Maryland, USA.
Richard L DotyUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
Todd A DurhamFoundation Fighting Blindness, Columbia, Maryland, USA.
Robert B HufnagelNational Eye Institute, Bethesda, Maryland, USA.
Mark H MyersUniversity of Tennessee Health and Science Center, Memphis, Tennessee, USA.
Katarina StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Wadih M ZeinNational Eye Institute, Bethesda, Maryland, USA.
Foundation Fighting Blindness Consortium Investigator Group
Foundation Fighting Blindness · USJaeb Center for Health Research · USNational Eye Institute · USUniversity of Pennsylvania · USCentre National de la Recherche Scientifique · FRDuke University · USNational Institutes of Health · USSTZ eyetrial · DEUniversity of California, San Francisco · USUniversity of Memphis · USUniversity of Tennessee Health Science Center · USUniversity of Utah · US

Funding

Clinical Analysis Of Disorders Of Hearing And BalanceZIADC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI HERTZANO, RONNA · 2009 to 2025
$25.2M
Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
Genomic and epigenomic mechanisms of pediatric ocular disordersZIAEY000565 · NEI · NATIONAL EYE INSTITUTE · PI HUFNAGEL, ROBERT · 2019 to 2024
$11.4M
Natural History of ABCA4-Related RetinopathiesZIAEY000534 · NEI · NATIONAL EYE INSTITUTE · PI BROOKS, BRIAN · 2013 to 2025
$5.3M
Natural History and Genetic Studies of Usher SyndromeZIAEY000528 · NEI · NATIONAL EYE INSTITUTE · PI ZEIN, WADIH · 2012 to 2025
$3.6M
Neuroimaging biomarkers of speech processing deficits in MCIR01DC016267 · NIDCD · UNIVERSITY OF MEMPHIS · PI BIDELMAN, GAVIN M. · 2018 to 2022
$2.1M
Foundation Fighting Blindness RUSH2A - CONSORTIUM - 2016Intramural NIH HHS ZIA DC000064NEI NIH HHS NEI-P30 EY002162NEI NIH HHS P30 EY002162NIDCD NIH HHS R01 DC016267
6 · The paper itself

Abstract

Sensorineural hearing loss (SNHL) is characteristic of Usher syndrome type 2 (USH2), but less is known about SNHL in nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) and olfaction in USH2A-associated retinal degeneration. The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) is a natural history study that enrolled 127 participants, 80 with USH2 and 47 with ARRP. Hearing was measured by pure-tone thresholds and word recognition scores, and olfaction by the University of Pennsylvania Smell Identification Test (UPSIT). SNHL was moderate in 72% of USH2 participants and severe or profound in 25%, while 9% of ARRP participants had moderate adult-onset SNHL. Pure-tone thresholds worsened with age in ARRP but not in USH2 participants. The degree of SNHL was not associated with other participant characteristics in either USH2 or ARRP. Median pure-tone thresholds in ARRP participants were significantly higher than the normative population (p < 0.001). Among 14 USH2 participants reporting newborn hearing screening results, 7 reported passing. Among RUSH2A participants, 7% had mild microsmia and 5% had moderate or severe microsmia. Their mean (±SD) UPSIT score was 35 (±3), similar to healthy controls (34 [±3]; p = 0.39). Olfaction differed by country (p = 0.02), but was not significantly associated with clinical diagnosis, age, gender, race/ethnicity, smoking status, visual measures, or hearing. Hearing loss in USH2A-related USH2 did not progress with age. ARRP patients had higher pure-tone thresholds than normal. Newborn hearing screening did not identify all USH2A-related hearing loss. Olfaction was not significantly worse than normal in participants with USH2A-related retinal degeneration.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAge of OnsetExtracellular Matrix ProteinsFemaleHearing Loss, SensorineuralHumansMaleMiddle AgedMutationPedigreeRetinal DegenerationRetinitis PigmentosaSmellUsher SyndromesExtracellular Matrix ProteinsUSH2A protein, humanautosomal recessive retinitis pigmentosaolfactionsensorineural hearing lossUsher syndrome type 2

Identifiers

PMID34331386
PMCPMC8717864
OpenAlexW3186516748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.